Effect of metoclopramide dose on preventing emesis after oral administration of N-acetylcysteine for acetaminophen overdose

Journal of Toxicology - Clinical Toxicology

Volumn 37, Issue 1, 1999, Pages 35-42

  Wright, Robert O ^a,d   Anderson, Angela C ^a   Lesko, Samuel L ^b   Woolf, Alan D ^c   Linakis, James G ^a   Lewander, William J ^a  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; METOCLOPRAMIDE; PARACETAMOL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG OVERDOSE; EMERGENCY TREATMENT; FEMALE; HUMAN; MALE; TREATMENT OUTCOME; VOMITING;

ACETAMINOPHEN; ACETYLCYSTEINE; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; ANTIDOTES; ANTIEMETICS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; OVERDOSE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EMESIS;

EID: 0032977107     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-100102406     Document Type: Article

References (19)

1. Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics 1975;55:871-876.
2. Litovitz TL, Smilkstein M, Felberg L, et al. 1996 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 1997;15:447-500.
3. Kobrinsky NL, Hartfield D, Horner H, et al. Treatment of advanced malignancies with high dose acetaminophen and N-acetylcysteine rescue. Cancer Invest 1996;14:202-210.
4. Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylsteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med 1988;319:1557-1562.
5. Rumack B. Acetaminophen in Poisindex. Micromedix Inc. Englewood, CO. 1997:93.
6. Clark RF, Chen R, Williams SR, Johnson CL, Harchelroad F. The use of ondansetron in the treatment of nausea and vomiting associated with acetaminophen poisoning. J Toxicol Clin Toxicol 1996; 34:163-167.
7. Tobias JD, Gregory DF, Deshpande JK. Ondansetron to prevent emesis following N-acetylcysteine for acetaminophen intoxication. Pediatr Emerg Care 1992;8:345-346.
8. Reynolds JC, Putnam PE. Prokinetic agents. Gastroenterol Clin North Am 1992;21:567-596.
9. Physicians Desk Reference Medical Economics Data Production Company Montvale, NJ. 1997:51.
10. Gralla RJ, Itri LM, Pisko SE, et al. Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 1981;305:905-909.
11. Strum SB, McDermed JE, Opfell RW, Riech LR. Intravenous metoclopramide: An effective antiemetic in cancer chemotherapy. JAMA 1982;247:2683-2686.
12. Meyer BR, Lewin M, Drayer DE, Pasmantier M, Lonski L, Reidenberg MM. Optimizing metoclopramide control of cisplatin-induced emesis. Ann Intern Med 1984;100:393-395.
13. Miettinen OS. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-235.
14. Armitage P. Statistical Methods in Medical Research. New York: John Wiley and Sons, Inc., 1971: 319-320.
15. Evelyn KA, Malloy HT. Microdetermination of oxyhemoglobin and sulfhemoglobin in a single sample of blood. J Biol Chem 1938;126:655-662.
16. Kahn T, Elias EG, Mason GR. A single dose of metoclopramide in the control of vomiting from cisdichlorodiammineplatinum (II) in man. Cancer Treat Rep 1978;62:1106-1107.
17. Moertel CG, Reitemeier RJ. Controlled clinical studies of orally administered antiemetic drugs. Gastroenterology 1969;57:262-268.
18. Rodgers G, Matyunas N, Ross M, Spiller R, Reibel J. Sulfhemoglobinemia associated with N-acetylcysteine therapy of acetaminophen overdose: A case report. J Toxicol Clin Toxicol 1995;33:530.
19. Tschekunow H, Delgado P, Shih, Jennis T, Ruck B, Marcus S. Sulfhemoglobinemia with metoclopramide therapy in a patient receiving N-acetylcysteine. J Toxicol Clin Toxicol 1996;34:554.